An update on the clinical development of dalcetrapib (RO4607381), a cholesteryl ester transfer protein modulator that increases HDL cholesterol levels.
about
Genotype-Dependent Effects of Dalcetrapib on Cholesterol Efflux and Inflammation: Concordance With Clinical OutcomesA vaccine targeted at CETP alleviates high fat and high cholesterol diet-induced atherosclerosis and non-alcoholic steatohepatitis in rabbit.Identification of a novel, non-tetrahydroquinoline variant of the cholesteryl ester transfer protein (CETP) inhibitor torcetrapib, with improved aqueous solubility.
P2860
An update on the clinical development of dalcetrapib (RO4607381), a cholesteryl ester transfer protein modulator that increases HDL cholesterol levels.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
An update on the clinical deve ...... reases HDL cholesterol levels.
@en
type
label
An update on the clinical deve ...... reases HDL cholesterol levels.
@en
prefLabel
An update on the clinical deve ...... reases HDL cholesterol levels.
@en
P2093
P2860
P356
P1433
P1476
An update on the clinical deve ...... reases HDL cholesterol levels.
@en
P2093
Benoit J Arsenault
David Rhainds
Jean-Claude Tardif
Mathieu R Brodeur
P2860
P304
P356
10.2217/FCA.12.25
P577
2012-07-01T00:00:00Z